Supporting Table 3 - Plos

Recommend Documents

Table S5: The coordinates and sequences of the 20 bp sequence tags flanking each of the 114 a-right"128T repeats in strains Z2491, MC58 and FAM18.

Supporting Table 1 - PLOS

Bim. TGCGCCCGGAGATACGGATT. TGGTCTTCAGCCTCGCGGTA. Bmf. TGTCATGCTGCCTTGTGG. TGAGCCTGCAGGGAAACTG. NOX4.

SUPPORTING INFORMATION Supplementary Table 4 - Table ... - PLOS

Supplementary Table 4 - Table S4: Results of Mann-Whitney U test (mean rank and sum of ranks) for comparison of bacterial density (cells/mL X 108) in the ...

Supporting Table S2.xlsx - PLOS

Table S2 page 1/182. Page 2. Table S2 page 2/182. Page 3. Table S2 page 3/182. Page 4. Table S2 page 4/182. Page 5. Table S2 page 5/182. Page 6 ...

Supporting Information Table S2 - PLOS

0.36. 0.35. 0.34. 0.49. 0.42. 0.78. 0.80. 0.51. 0.27. 0.41. 0.29. 0.27. 0.42. 0.32 rs4836493. Chr 5,. 129,499,621. CSS3. GWAS. A/G. 0.11/0.07. Allelic. Additive.

Supporting data 3 - PLOS

465..472. MYH10. Homo sapiens myosin, heavy chain 10, non-muscle class II. 4628. 55941. 41406064. 87..771. 238..243. 460..467. MYH11. Homo sapiens.

supporting file 3 - Plos

Oct 10, 2012 - serological status and you find that this is not due taking medicine. ... that her husband told her that if she gave birth to another girl, she would go back to her family ... to constantly thinking about her parents. .... secret". The

Supporting data 3 - PLOS

myosin, heavy chain 1, skeletal muscle, adult class II. 4619. 117708. 115527082. 89..770. 243..248. 465..472. MYH10. Homo sapiens myosin, heavy chain 10, ...

Supporting Table 3. Vector toolkit: features and database and ... - PLOS

Kanamycin. spisPink. Level 1 cloning: Assembly of standard parts into a TU or augmentation of high-order multi-TUs. pMA_Level1Î. MG252983. 102702. pMB1.

Table 3 - PLOS

mRNA_processing_binding_Reactome(Ddx1, Snrpc, Eif4a3, Brca1,. Cugbp1). RNA_transcription_Reactome(Taf9, Gtf2e2). DNA_replication_Reactome(Cdc7 ...

Supplementary Table 3 - Plos

Predictive modeling with the Weka data mining platform. Weka software ... The following sections describe these steps in more detail. Selecting informative ...

Supplementary Table 3 - Plos

13. 39% 8.24E-08. V$TAXCREB_02. 84. 33. 39% 1.33E-15. V$TFIII_Q6. 140. 55 ... 7. 32% 0.000408. V$GATA1_03. 139. 44. 32%. 2E-15. V$HNF1_01. 179. 56. 31% 2.66E-15. V$NFKAPPAB_01. 77. 24. 31% 9.88E-11. V$OCT1_B. 276. 86.

Supplementary Table 3.xlsx - Plos

Patient ID U6B-âPTC-âN. U6B-âPTC-âT. GAPDH-âPTC-âN. GAPDH-âPTC-âT. 537. 29.21. 27.29. 24.77. 25.03. 548. 30.83. 29.63. 25.98. 26.67. 1501. 26.43.

SUPPORTING METHODS S1 Table of Contents - PLOS

the second term of Eq. 6 (main text) using A=0.8 10. -20. J. It is very important to control the pH of the solution before and after AFM measurements in order to.

Core, et al. Supporting Table 2 - PLOS

Table S2. Arthropod Pathogen Microarray results. Location codes are main study hive (HHH), stranded on landing near main hive (HHL), main hive enclosure ...

Supplemental Table 3-merged lists - PLOS

PPAP2A. 2.0E-07. 1.59 PPAP2A. 4.9E-03. 2.18. 209147_s_at PPAP2A. 6.5E-07. 1.59 PPAP2A. 4.8E-03. 2.15. 207808_s_at PROS1. 3.3E-05. 1.58 PROS1.

Supplemental table 3- Mutation Status - PLOS

Calu. 3. NSCLC. AD. WT. WT. WT. WT. WT. WT nd. H. 23. NSCLC. AD. WT. Yes. WT. WT. WT nd nd. H. 157. NSCLC. SQ. WT. Yes. WT. WT. WT nd nd. H. 226.

S4 Table. Statistical analysis for data in Table-3. - PLOS

Statistical analysis for data in Table-3. GluN1/GluN2A. GluN1/GluN2B. ANOVA. Post hoc Tukey's P-value. ANOVA. Post hoc Tukey's P-value. F statistic. P value.

Supporting table 1

Dinoflagellate Pfiesteria piscicida (Peridiniales, Alveolata). Gwang Hoon Kim, Hae Jin Jeong, Yeong Du Yoo, Sunju Kim, Ji Hee Han, Jong Won. Han, Giuseppe ...

Supporting Table S1.xlsx

Table S1 page 1/159. Page 2. Table S1 page 2/159. Page 3. Table S1 page 3/159. Page 4. Table S1 page 4/159. Page 5. Table S1 page 5/159. Page 6. Table ...

Supporting Table 3. Results of individual studies and risk of ... - PLOS

... the intervention compared to the 6 months before*:. Î = -83.1% (complete treatment cessation for 27% of patients). switch to chloral hydrate, diphenhydramine.

Supporting Information: Table S1. LSD1/NuRD complex ... - PLOS

Peptides derived from LSD1/NuRD complex components MTA2, HDAC2, RbAp46 and MBD3 are listed. Prox1-derived peptides are also shown as indicator of ...

Supporting Information Table S3: Overview of the studies ... - PLOS

Supporting Information Table S3: Overview of the studies included in the age-specific meta-analyses of functional underactivation. Year. First author. Native.

Supporting Information Table 1 The serine protease inhibitors ... - PLOS

TIL. Yes. BmSPI28 BGIBMGA004726. BmSPI29 BGIBMGA007721. BmSPI30 BGIBMGA004736. BmSPI31 BGIBMGA013903. BmSPI32 BGIBMGA013848.

Supporting Table 3 - Plos

Download PDF

10 downloads 0 Views 179KB Size Report

Comment

Akap4 (site 1) Fw 5'- TCAGAGCCAGCAGGAAACAG -3'. Rev 5' - CCCTTTAGATGGAAGGGGGC -3'. Akap4 (site 2) Fw 5'- GAGGCGTGTGCAAGGTAGAT -3'.

Supporting Table 3 Real-time PCR primer sequences for ChIP assays used in the study ChIP primers Ctnnd2 (exon)

Fw 5’- ACCCCCTCTGCCTTCTCTCT -3’ Rev 5’- GCCACTGCACACACTACACG -3’

Ctnnd2 (intron) Fw 5’- GCTCATGGATGCAGTCCCCA -3’ Rev 5’- CGGACTGCCTAGCCCTGTTG -3’ Mpped1 (exon) Fw 5’- GGTCTGACAGGTGCGTGCTT -3’ Rev 5’- GTCAGGAGTTCCGGGGTGTG -3’ Mpped1 (intron) Fw 5’- CAGTGTAGGGGGTTGCCTGC -3’ Rev 5’- CACTCAGGATGCCCCAAGCC -3’ Cntn1 (exon)

Fw 5’- AGGTTCGAGCACACAGCGAC -3’ Rev 5’- CGCTGATGTTGTGAACGCCG -3’

Cntn1 (intron)

Fw 5’- ACCTTGGTCCAGGCAAGCAC -3’ Rev 5’- CCCTCCAGGGTAGGCACTGT -3’

Pkib (exon)

Fw 5’- TGGTCCCGTTGATCCTTGGACT -3’ Rev 5’- AGGCCAGTCTCTCCCTAGCCA -3’

Pkib (intron)

Fw 5’- GTGTGAGCCGCTTCCTTCCC -3’ Rev 5’- GAGACAGCAAATGTGCCTCGGT -3’

Tbata (exon)

Fw 5’- ACACCCAGTGCCTACCGCTT -3’ Rev 5’- CCGCGGCCGTACCTTGGATA -3’

Tbata (intron)

Fw 5’- CTCCCCCACCTCCTGGCAAA -3’ Rev 5’- AGTCCTGCACGCTGGGATGT -3’

Slain2 (exon)

Fw 5’- AGTCCAAATGCCAGTAGCCCATACA -3’ Rev 5’- AGCTGCTTGACTATGGGAGGTCG -3’

Slain2 (intron)

Fw 5’- TGTGCTTGTGTGCACCACTTTGA -3’ Rev 5’- AGAGAAAACAAGCCACCAGCAAACA -3’

Akap4 (site 1)

Fw 5’- TCAGAGCCAGCAGGAAACAG -3’ Rev 5’ - CCCTTTAGATGGAAGGGGGC -3’

Akap4 (site 2)

Fw 5’- GAGGCGTGTGCAAGGTAGAT -3’ Rev 5’- TGGAGAAGCCACATACCAGC -3’

Akap4 (site 3)

Fw 5’- GCAATCAGAGGTCAGTTGCCA -3’ Rev 5’- TTACGGGCCATTTGGATTACCA -3’

Il2rg (site 1)

Fw 5’- CCATGGTGCCAACAGGGATA -3’ Rev 5’- GTGCCTGGCATCCATGTCTT -3’

Il2rg (site 2)

Fw 5’- TACCGTTTCAGCTCATCCACA -3’ Rev 5’-AACGATCTATCCCTCACCCTTCT -3’

Il2rg (site 3)

Fw 5’- CCCTTTCCCCATAGCCTTCC -3’ Rev 5’- GTCCTCATGTCCAGTGCGAA -3’

Akap14 (site 1) Fw 5’-TATGCTTGGTCTCAGTAATGTCC -3’ Rev 5’ - CCTTCCTCTACAGACCAGGAGAA -3’ Akap14 (site 2) Fw 5’- AGATGTAAGAGACATCAACAGGCA -3’ Rev 5’- TGGGAGGATTAAGCATCGGC -3’ Akap14 (site 3) Fw 5’- AAGAGCTTACGGCAGGTTTG -3’ Rev 5’- ACTATATCTACCGGGTGCGCT -3’